Latest news
Satellite Bio Announces FDA Clearance of IND Application for SB-101 for the Treatment of Urea Cycle Disorders (UCDs) Marking its Transition to a Clinical-Stage Biotechnology Company - BioSpaceBioSpace · Wed, 05 Aug 2026 03:09:09 GMTFDA grants Fast Track designation to XellSmart's off-the-shelf Parkinson's cell therapy XS411 - AllSciAllSci · Tue, 04 Aug 2026 14:35:12 GMTFDA Grants Fast Track Designation to Xellsmart Off-The-Shelf Cell Therapy for Parkinson's Disease - Yahoo Finance SingaporeYahoo Finance Singapore · Tue, 04 Aug 2026 12:21:00 GMTGenetic clues for cell therapy toxicities; Summit’s high-stakes FDA decision - Pharma VoicePharma Voice · Fri, 31 Jul 2026 13:20:07 GMTBMS and Gilead rule in the CAR-T space. Off-the-shelf developers aren’t trying to change that. - Pharma VoicePharma Voice · Wed, 29 Jul 2026 07:00:00 GMT